Compare VICI Properties Inc (VICI) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VICI Properties Inc vs Zimmer Biomet Holdings Inc — how do they compare? VICI Properties Inc trades at $25.3 (market cap $27.82B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $17.97B). The key difference: VICI Properties Inc is the larger of the two by market cap, and VICI Properties Inc pays the higher dividend (7.28%). Which is the better fit depends on your goals.
| VICI | ZBH | |
|---|---|---|
Market Cap | $27.82B | $17.97B |
Sector | Real Estate | Health |
52-Week High | $33.16 | $104.26 |
52-Week Low | $25.23 | $79.58 |
Enterprise Value | $45.38B | $25.04B |
Dividend Yield | 7.28% | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VICI trades at $25.29, down 0.51% today, with a bearish technical signal from moving averages but oversold RSI readings. The stock offers a high dividend yield above 7%, supported by strong profitability margins (net income margin 67.5% in 2025) and a low P/E of 9.79. Recent corporate actions include a dividend increase to $0.46 per share and the appointment of a new independent director, reflecting steady governance.
Outlook remains positive with a consensus price target of $29.29 (16% upside), driven by stable cash flows and REIT income appeal. Risks include earnings volatility (two recent EPS misses) and acquisition yield pressures. Institutional sentiment is bullish (77% buy ratings), but technical weakness near support at $25 requires monitoring for entry opportunities.
Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.
The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
